Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transplantation outcomes in patients with Down syndrome-associated acute lymphoblastic leukaemia: Implications for treatment intensity and the use of novel therapies.

British journal of haematology·2026
Same author

Idiopathic Pulmonary Hemosiderosis Complicated by Direct Antiglobulin Test-negative Autoimmune Hemolytic Anemia.

Journal of pediatric hematology/oncology·2025
Same author

Outcome of hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia not in remission enrolled in JACLS ALL-02.

International journal of hematology·2023
Same author

Prednisolone poor response is not an indication for HSCT in pediatric B-cell precursor acute lymphoblastic leukemia in first remission: results from JACLS ALL-02 study.

International journal of hematology·2021
Same author

Leukemic cells expressing NCOR1-LYN are sensitive to dasatinib in vivo in a patient-derived xenograft mouse model.

Leukemia·2020
Same author

Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.

Blood advances·2019

相关实验视频

Updated: Jun 11, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.0K

[用L-阿斯巴拉金酶治疗的进展]

Mio Yano1

  • 1Department of Pediatrics, Kyoto City Hospital.

[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 2, 2024
PubMed
概括

对于治疗急性淋巴细胞白血病/淋巴细胞淋巴瘤在所有年龄段至关重要. 通过管理副作用和治疗药物监测来确保治疗完成对于更好的生存结果至关重要.

科学领域:

  • 在瘤学瘤学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • L-阿斯巴拉金酶是急性淋巴细胞白血病/淋巴细胞淋巴瘤的关键化疗剂.
  • 完成治疗对于改善患者生存结果至关重要.

研究的目的:

  • 审查L-阿斯巴拉金酶治疗的进展.
  • 概述目前和未来在最大限度地提高L-阿斯巴拉金酶的疗效和安全方面的挑战.

主要方法:

  • 关于L-阿斯巴拉金酶治疗的文献综述.
  • 对管理不良事件和优化管理的策略的分析.

主要成果:

  • 对过敏反应和其他不良事件的有效管理是关键.
  • 治疗药物监测有助于优化L-asparaginase的使用.
  • 日本的新型L-asparaginase制剂为改善治疗提供了潜力.

结论:

  • 为了最大限度地提高治疗效果,需要解决管理方面的挑战和不良事件.
  • 继续研究和战略性使用L-阿斯巴拉金酶对于改善白血病治疗至关重要.
关键词:
急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.在L-asparaginase的使用中.淋巴细胞淋巴瘤是淋巴细胞淋巴瘤.新批准的药物新批准的药物

更多相关视频

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.1K

相关实验视频

Last Updated: Jun 11, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.0K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.1K